Investors have to get real about Healthcare
June 1, 2011
U.S. scores dead last again in healthcare study | www.reuters.com
Healthcare costs are crippling America’s competiveness and our economic recovery. They are about 20% of the US economy and over 30% of the total Federal Budget. The healthcare debate rages on, however, with complete disregard of the proven facts on how to reduce healthcare costs and improve quality and access.
Distinguishing Fact from Fiction in Care Management Outcomes Reports
March 8, 2011
States Take Lead in Adopting Medical Home Models | www.aafp.org
Too many bad policy decisions are made based on published, often peer-reviewed studies in which the numbers simply don't add up. The most often-cited example in patient-centered medical homes is the North Carolina Medicaid Community Care Access Program, alleged to save $300,000,000/year by now. However, the keynote at next week's Disease Management Colloquium in Philadelphia (www.dmconferences.com) will demonstrate that this number is fictional, and is easily refuted by actual data.
Investor Opportunities in the HR Space
July 30, 2010
Aon buys Hewitt in a move to expand its Consulting Arm | www.nytimes.com
We are in the midst of the most rapid Global Organizational Transformation of Industry that has ever occurred. Organizations are recognizing the opportunities for using new Human Capital strategies and technology to change outdated concepts and more effectively drive value and improve productivity through people.This is dramatically changing the landscape of the HR Consulting and Outsourcing market, and new players are emerging in this $20bn+ global marketplace.
A Fresh Perspective on Executive Compensation levels in the Finance industry
March 8, 2010
US Financial Firms' Top Executive Bonuses Up 17 Percent in 2009 | www1.voanews.com
We are justifying enormous compensation packages in the Finance Industry particularly to "purchase" a business risk insurance caused by the impact of technology and the outdated organizations that have an over concentration of risk in key individuals and roles. Management's false argument is that they have to do it to retain key talent.Because internal equity is a key element of compensation design the senior management have a vested interest in the people working for them being highly paid.
A fresh perspective of Executive Compensation Levels and Business Risk
January 20, 2010
SIMFA Guidelines for Compensation | www.sifma.org
Executive Compensation has become such an emotive issue that the key points are being missed and shareholders are confused about the logic behind reasonable compensation. Investors need to look not only at fundamental incentive compensation practices and their impact on risk taking, they need also to be looking at the concentration of business risk in key individuals, indicated by the justification for excessive compensation levels.
What is the Future for the US Health Care Industry?
October 15, 2009
Facts on Healthcare | www.nchc.org
What is really going on in our Health Care Industry is being blurred with emotion, politics and self interest propaganda. Any of the other major industrial countries would provide regulated quality Universal Healthcare for more than $1 trillion dollars less than we are spending now. This waste is draining about $500 billion of our tax dollars, $300 billion of corporate expense and $200 billion of consumer spending. The key question is, "is Regulating the Health Care Industry inevitable?"
We have to burst the Healthcare Bubble
February 2, 2009
Facts on Healthcare | www.nchc.org
We have the world's most expensive healthcare system costing $2.4 trillion per Year 4.3 times more than we spend on national defense, 20% of GDP. It is also one of the world's worst systems ranked 37th by the World Health Organization. Costs are escalating at 7%, at least twice the rate of inflation. Our Healthcare System is the most inefficient and wasteful among leading industrial countries. Other countries with some regulation, provide Universal Healthcare for about half of the cost of our system, which does not. We can support economic recovery through healthcare reform. About 46% of the US population is receiving government provided healthcare at a cost of $1 trillion. This includes politicians, prisoners, armed forces, federal and state employees and Medicaide and Medicare recipients. There is little central purchasing power leverage and billions of our tax dollars are being wasted along with billions of dollars of philanthropic, employer, employee and individuals monies.
Turbocharging organization capability a la Google
March 5, 2008
Management a la Google, WSJ 4/26/2006 | online.wsj.com
Nearly all major companies are operating outdated organizational concepts that support egos and greed but do not use people and technology to maximize investor value. A few companies are challenging these concepts, Google being one, but no company has made the transformation to a truly "intelligent organization". The first company that establishes a true value focused culture and organization which recognises how people drive value and supports them with the technology that is now available will gain tremendous competitive advantage.
PBM's Fail Employers with Mail
May 9, 2007
Comparison of Mail Order with community Pharmacy Cost | www.amcp.org
Mail did not produce higher generic utilization rates or lower costs for employers who hired a PBM to accomplish both.
Media Smells Blood at Big Pharma
April 2, 2007
Under The Influence | www.cbsnews.com
60 Minutes aired its story last night on the impact of The Pharmaceutical Lobby in writing and passing Medicare Prescription Drug Plan.
Over the course of the upcoming Presidential campaign the high cost of prescription drugs will become an issue and spill over into employer plans as well with implications for PBMS and Pharmaceutical Margins.
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011